latest news releases from the newsroom
Bioheart Announces Grant-Supported Study for the Bioheart A&C Bio Science Twin-Pulsatile Life Support System
SUNRISE, Fla., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc., (Nasdaq:BHRT) today announced it has arranged with its local partner, Biomedica, in Italy, for a complete grant-supported study of the Bioheart A&C Bio Science T-PLS(r) Twin-Pulsatile Life Support System, a blood pump that is introduced through small percutaneous punctures into the femoral artery and femoral vein of a patient. The first shipments were made this week to a hospital in Italy, and testing on the system should be completed within 45 days. If the test results are positive, sales forecast for the systems in Italy alone for 2009 will be approximately 35 units at $60,000 each, for a total contract value estimated at $2,100,000.
School Specialty, Inc
School Specialty Schedules Third Quarter Conference Call
GREENVILLE, Wis., Feb. 3, 2009 (GLOBE NEWSWIRE) -- School Specialty (Nasdaq:SCHS), a leading education company providing supplemental learning products to the PreK-12 market, has scheduled its fiscal 2009 third quarter earnings conference call for Thursday, February 19 at 11 a.m. Eastern Time. The company's third quarter earnings news release will also be issued February 19, before the open of trading on the Nasdaq Market.
BQE Software Achieved Gold Certified Partner Status in Microsoft Partner Program
LOS ANGELES, Feb. 3, 2009 (GLOBE NEWSWIRE) -- BQE Software Inc., the makers of BillQuick, time tracking, billing and project management solutions, announced today that it has achieved the Gold Certified Partner status in the Microsoft Certified Partner (MCP) program with a competency in ISV/Software Solutions.
Emisphere Technologies, Inc.
Emisphere to Present At 11th Annual BIO CEO & Investor Conference
CEDAR KNOLLS, N.J., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its Eligen(r) Technology, today announced that President and Chief Executive Officer, Michael V. Novinski, will present at the 11th Annual BIO CEO & Investor Conference at 11:30 AM EST on Tuesday, February 10, 2009. The BIO CEO Conference is being held at the Waldorf-Astoria Hotel in New York City.
Strativity Group, Inc.
Strativity Group Announces Performance Excellence(tm) -- Customer Experience Best Practices Database
ROCHELLE PARK, N.J., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Strativity Group announced today the launch of Performance Excellence(tm), its proprietary database containing over 1,000 customer experience management best practices. The database was created and deployed by Strativity and contains researched best practices utilized by clients and leading customer-centric organizations. The database provides Strativity Group with a unique competitive advantage allowing it to quickly utilize proven practices and resolutions to address specific client issues.
TF Financial Corporation
TF Financial Corporation Declines to Participate in TARP
NEWTOWN, Pa., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Kent Lufkin, President and CEO of TF Financial Corporation (Nasdaq:THRD), holding company for Third Federal Bank, today announced that the Company has declined to participate in the U. S. Treasury Department's Troubled Asset Relief Capital Purchase Program (TARP). The Company was recently notified that it has been preliminarily approved for TARP. After careful consideration, the Company decided not to participate in the program.
EMS Technologies, Inc.
EMS Technologies to Build Seeker Antenna for Joint Air-to-Ground Missile Development Program
ATLANTA, Feb. 3, 2009 (GLOBE NEWSWIRE) -- EMS Technologies, Inc. (Nasdaq:ELMG) announced today that Lockheed Martin (NYSE:LMT) has awarded EMS Defense & Space a contract for production and capability enhancement work on the millimeter wave radar antenna as part of its recently announced $122 million Technology Development (TD) contract for the Joint Air-to-Ground Missile (JAGM) program.
Protea Biosciences, Inc.
Photo Release -- Protea Releases New Proteomics Technology Platform
MORGANTOWN, W.Va., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leader in the development of new protein research technology, announced today the commercial launch of its new protein recovery technology platform, the GPR-800. Protea's new instrument offers the simultaneous recovery of eight proteins from gels in less than 20 minutes.